Literature DB >> 2592771

Mast cells chemotax to laminin with enhancement after IgE-mediated activation.

H L Thompson1, P D Burbelo, Y Yamada, H K Kleinman, D D Metcalfe.   

Abstract

The increase of mast cells at sites of tissue inflammation suggests the production of local factors chemotactic for mast cells. In this report, we demonstrate that the murine mast cell line PT18 and primary mouse bone marrow-derived mast cells chemotax to the basement membrane glycoprotein laminin, and that the synthetic laminin A chain-derived peptide, PA22-2, represents a region of laminin that contains a major chemoattractant site. Mast cell chemotaxis to laminin is enhanced after activation of mast cells by the calcium ionophore, A23187, or PMA and by sensitization of the cells with IgE followed by exposure to antigen. Chemotaxis is not increased in the presence of IL-3 and is independent of mast cell degranulation, as histamine release did not occur when cells were activated with PMA. Mast cell chemotaxis to laminin and its enhancement by IgE-dependent mast cell activation provides a mechanism by which these cells may be attracted to sites of tissue injury. Such activity may be particularly relevant in the response of host tissues to inflammation accompanying parasitic infestations, allergic reactions, and wound healing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592771

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Characterization of purification-associated reduction in IgE-dependent histamine release from rat peritoneal mast cells.

Authors:  N Inagaki; H Kawasaki; H Nagai
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

2.  Mast cells: the forgotten cells of renal fibrosis.

Authors:  I S Roberts; P E Brenchley
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

Review 3.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

4.  Sequential mast cell infiltration and degranulation during experimental carcinogenesis.

Authors:  E A Flynn; J L Schwartz; G Shklar
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.

Authors:  M Wroblewski; R Bauer; M Cubas Córdova; F Udonta; I Ben-Batalla; K Legler; C Hauser; J Egberts; M Janning; J Velthaus; C Schulze; K Pantel; C Bokemeyer; S Loges
Journal:  Nat Commun       Date:  2017-08-16       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.